Lebanon

BMI View: The strength of the Lebanese drugmaker Pharmaline is in the marketing and branding of its drugs and itself. By focusing on obtaining international standards and emphasising... 2011-09-22

BMI View: The wider use of Trade-Related Aspects of Intellectual Property Rights (TRIPS), which aims to harmonise intellectual property (IP) and codify patent rights, will, in the long... 2011-05-25

BMI View: Lebanon spends an uncharacteristically large proportion of its national income on pharmaceuticals and healthcare. Like Greece in Europe, this statistical abnormality makes... 2011-04-28

BMI View: Political stability, a cost-effective healthcare system and an established tourism sector are fundamental prerequisites for developing a medical tourism industry. Therefore,... 2010-11-17

BMI View: Lebanon's decision to allow the registration and therefore import of Jordanian medicines presents opportunities for Jordanian firms to expand regionally and also adds an... 2010-05-12

The latest submission by the PhRMA to the upcoming 2010 Special 301 report by the US Trade Representative (USTR) has placed Algeria and Lebanon on the priority watch list, while Saudi... 2010-03-15

The Lebanese customs department has seized large quantities of fake medicines at a pharmaceutical manufacturing plant in the country. The amount of drugs seized was not disclosed,... 2010-02-25